kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Human CD80 / B7-1 Protein, His tag (MALS verified), 100µg  

Recombinant Human CD80 / B7-1 Protein, His tag (MALS verified), 100µg

Recombinant Human B7-1 / CD80 Protein (Val 35 - Asn 242), produced in human HEK293 cells, His tag (MALS verified)

recombinant human protein CD80, B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7

More details


Availability: within 7 days

336,00 €

B7-1 and B7-2, together with their receptors CD28 and CTLA­4, constitute one of the dominant co-stimulatory pathways that regulate T­ and B­cell responses. Although both CTLA­4 and CD28 can bind to the same ligands, CTLA­4 binds to B7­1 and B7­2 with a 20 ­ 100 fold higher affinity than CD28 and is involved in the down­regulation of the immune response. B-lymphocyte activation antigen B7-1 (referred to as B7) also known as cluster of Differentiation 80 (CD80), is a member of cell surface immunoglobulin superfamily and is expressed on activated B cells, activated T cells, macrophages and dendritic cells. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. CD80 plays a role in induction of innate immune responses by activating NF-κB-signaling pathway in macrophages. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

Recombinant Human B7-1, His Tag (B71-H5228) is expressed from human 293 cells (HEK293). It contains AA Val 35 - Asn 242 (Accession # P33681-1).
Predicted N-terminus: Val 35

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 25.8 kDa. The protein migrates as 40-60 kDa under reducing (R) condition (SDS-PAGE) due to different glycosylation.

Less than 1.0 EU per μg of the rhCD80 by the LAL method.

>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally Mannitol or Trehalose are added as protectants before lyophilization.

See Certificate of Analysis for details of reconstitution instruction and specific concentration.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Please refer to product data sheet.

Clinical and Translational Updates

(1) "Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice"
Cao, Tian, Nguyen et al
FASEB J (2021) 35 (9), e21801
(2) "Dried Blood Specimens as an Alternative Specimen for Immune Response Monitoring During HIV Infection: A Proof of Concept and Simple Method in a Pediatric Cohort"
Rubio-Garrido, Avendaño-Ortiz, Ndarabu et al
Front Med (Lausanne) (2021) 8, 678850
(3) "Prevention of CD8 T Cell Deletion during Chronic Viral Infection"
Brooks, Tishon, Oldstone et al
Viruses (2021) 13 (7)
Showing 1-3 of 5966 papers.
Please refer to product data sheet.

The following products could also be interesting for you: